18 Grants
2018
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA175772-05), $282,926USD, 01/01/2014 -- 12/31/2018
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA175772-05S1), $83,021USD, 01/01/2014 -- 12/31/2018
2017
Molecular determinant of racial disparity in prostate cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3U01CA185490-04S1), $41,253USD, 05/09/2014 -- 04/30/2019
 
Molecular determinant of racial disparity in prostate cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA185490-04), $282,926USD, 05/09/2014 -- 04/30/2019
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA175772-04), $282,926USD, 01/01/2014 -- 12/31/2018
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA175772-04S1), $142,322USD, 01/01/2014 -- 12/31/2018
2016
Molecular determinant of racial disparity in prostate cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA185490-03), $314,363USD, 05/09/2014 -- 04/30/2019
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA175772-03S1), $78,765USD, 01/01/2014 -- 12/31/2018
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA175772-03), $314,363USD, 01/01/2014 -- 12/31/2018
2015
Molecular determinant of racial disparity in prostate cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U01CA185490-02), $313,931USD, 05/09/2014 -- 04/30/2019
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA175772-02), $313,585USD, 01/01/2014 -- 12/31/2018
2014
Molecular determinant of racial disparity in prostate cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1U01CA185490-01), $313,325USD, 05/09/2014 -- 04/30/2019
 
MRI: Acquisition of Scanning Transmission Electron Microscope System for Investigation and Characterization of Complex, Nanoscale Systems
Rich, Thomas⋅Palanki, Srinivas and Singh, Ajay
National Science Foundation (NSF), Directorate for Engineering, Division of Chemical, Bioengineering, Environmental, and Transport Systems (ID: 1428312), $700,000USD, 08/15/2014 -- 07/31/2017
 
Targeting tumor-stromal interaction for pancreatic cancer therapy
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA175772-01A1), $313,325USD, 01/01/2014 -- 12/31/2018
2013
Myb, a key driver of pancreatic cancer progression and metastasis
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA167137-02), $151,804USD, 04/01/2012 -- 03/31/2015
2012
Myb, a key driver of pancreatic cancer progression and metastasis
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA167137-01), $193,793USD, 04/01/2012 -- 03/31/2014
2010
MicroRNAs in Pancreatic Cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R03CA137513-02), $74,188USD, 07/20/2009 -- 06/30/2012
2009
MicroRNAs in Pancreatic Cancer
Singh, Ajay P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R03CA137513-01A1), $74,000USD, 07/20/2009 -- 06/30/2011